Log in to save to my catalogue

The CD47/TSP-1 axis: a promising avenue for ovarian cancer treatment and biomarker research

The CD47/TSP-1 axis: a promising avenue for ovarian cancer treatment and biomarker research

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_dd3b485e8ca3415e9aedea04cb9e8214

The CD47/TSP-1 axis: a promising avenue for ovarian cancer treatment and biomarker research

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Ovarian cancer (OC) remains one of the most challenging and deadly malignancies facing women today. While PARP inhibitors (PARPis) have transformed the treatment landscape for women with advanced OC, many patients will relapse and the PARPi-resistant setting is an area of unmet medical need. Traditional immunotherapies targeting PD-1/PD-L1 have fai...

Alternative Titles

Full title

The CD47/TSP-1 axis: a promising avenue for ovarian cancer treatment and biomarker research

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_dd3b485e8ca3415e9aedea04cb9e8214

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_dd3b485e8ca3415e9aedea04cb9e8214

Other Identifiers

ISSN

1476-4598

E-ISSN

1476-4598

DOI

10.1186/s12943-024-02073-0

How to access this item